FB418

· 1ST Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FB418, covering 2024-12-02 to 2024-12-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418 [Phase 1]